Buzatu, I.M.; Tataranu, L.G.; Duta, C.; Stoian, I.; Alexandru, O.; Dricu, A.
A Review of FDA-Approved Multi-Target Angiogenesis Drugs for Brain Tumor Therapy. Int. J. Mol. Sci. 2025, 26, 2192.
https://doi.org/10.3390/ijms26052192
AMA Style
Buzatu IM, Tataranu LG, Duta C, Stoian I, Alexandru O, Dricu A.
A Review of FDA-Approved Multi-Target Angiogenesis Drugs for Brain Tumor Therapy. International Journal of Molecular Sciences. 2025; 26(5):2192.
https://doi.org/10.3390/ijms26052192
Chicago/Turabian Style
Buzatu, Iuliana Mihaela, Ligia Gabriela Tataranu, Carmen Duta, Irina Stoian, Oana Alexandru, and Anica Dricu.
2025. "A Review of FDA-Approved Multi-Target Angiogenesis Drugs for Brain Tumor Therapy" International Journal of Molecular Sciences 26, no. 5: 2192.
https://doi.org/10.3390/ijms26052192
APA Style
Buzatu, I. M., Tataranu, L. G., Duta, C., Stoian, I., Alexandru, O., & Dricu, A.
(2025). A Review of FDA-Approved Multi-Target Angiogenesis Drugs for Brain Tumor Therapy. International Journal of Molecular Sciences, 26(5), 2192.
https://doi.org/10.3390/ijms26052192